Fullerton Fund Management Co Ltd. Invests $292,000 in Astera Labs, Inc. $ALAB

Fullerton Fund Management Co Ltd. purchased a new position in Astera Labs, Inc. (NASDAQ:ALAB) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 1,755 shares of the company’s stock, valued at approximately $292,000.

A number of other institutional investors also recently made changes to their positions in ALAB. Royal Bank of Canada raised its holdings in shares of Astera Labs by 167.3% in the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after acquiring an additional 95,409 shares during the last quarter. AQR Capital Management LLC raised its holdings in shares of Astera Labs by 213.4% in the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after acquiring an additional 7,756 shares during the last quarter. Empowered Funds LLC increased its stake in Astera Labs by 917.3% in the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock valued at $277,000 after purchasing an additional 4,183 shares during the last quarter. First Trust Advisors LP increased its stake in Astera Labs by 102.0% in the second quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock valued at $10,196,000 after purchasing an additional 56,952 shares during the last quarter. Finally, Brown Advisory Inc. increased its stake in Astera Labs by 54.9% in the second quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock valued at $505,000 after purchasing an additional 1,977 shares during the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Astera Labs

In related news, CEO Jitendra Mohan sold 325,693 shares of the stock in a transaction dated Friday, April 17th. The stock was sold at an average price of $172.14, for a total value of $56,064,793.02. Following the completion of the transaction, the chief executive officer owned 4,079,322 shares of the company’s stock, valued at approximately $702,214,489.08. This represents a 7.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the company’s stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total value of $116,120,000.00. Following the sale, the chief operating officer owned 5,064,213 shares in the company, valued at $1,470,141,033.90. The trade was a 7.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 2,161,256 shares of company stock valued at $459,844,296. Insiders own 10.40% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently commented on ALAB shares. UBS Group started coverage on Astera Labs in a research note on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 target price for the company. JPMorgan Chase & Co. upped their target price on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. TD Cowen upped their target price on Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a research note on Wednesday, May 6th. Royal Bank Of Canada upped their target price on Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research note on Wednesday, May 6th. Finally, Northland Securities lowered Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Tuesday, May 26th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $233.75.

Astera Labs Trading Down 7.1%

ALAB stock opened at $361.71 on Wednesday. The stock has a 50-day moving average price of $247.50 and a two-hundred day moving average price of $182.34. Astera Labs, Inc. has a 12-month low of $84.78 and a 12-month high of $398.13. The company has a market cap of $62.00 billion, a PE ratio of 244.40, a price-to-earnings-growth ratio of 5.15 and a beta of 3.94.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. During the same quarter in the prior year, the business earned $0.33 earnings per share. The company’s revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities analysts forecast that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.